SCHEMBL172121

SCHEMBL172121

Cc1ccc(CCS(=O)(=O)N2CCN(CCC(=O)c3ccc4[nH]c(=O)oc4c3)CC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 1/20 0.55
GRIN3B O60391 1/20 0.55
GRIN1 Q05586 1/20 0.55
GRIN2A Q12879 1/20 0.55
GRIN2B Q13224 1/20 0.55
GRIN2C Q14957 1/20 0.55
GRIN3A Q8TCU5 1/20 0.55
ENPP2 Q13822 6/20 0.54
KCNH2 Q12809 1/20 0.53
TSHR P16473 1/20 0.44
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
HTR1A P08908 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A3 Q01959 1/20 0.41
CREBBP Q92793 1/20 0.39
NOS1 P29475 1/20 0.39
ATXN2 Q99700 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL107008 0.91 ENPP2 (0.59) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL104294 0.91 ENPP2 (0.65) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL172076 0.85 ENPP2 (0.61) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL13137764 0.82 ENPP2 (0.59) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL108368 0.82 ENPP2 (0.61) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL2548653 0.80 ENPP2 (0.66) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL3053030 0.80 ENPP2 (0.83) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL109647 0.80 GRIN2B (0.76) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL109667 0.79 ENPP2 (0.61) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL1907303 0.77 ENPP2 (0.67) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2426106-A1 Piperidine and Piperazine derivatives for the treatment of tumours Merck Patent GmbH (DE) 2012-03-07 EP disclosed